1185255-99-5,
2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil,
N2-Ethyl candesartan cilexetilc,
Candesartan cilexetil impurity C [EP],
2-Desethyl-1H-1-ethyl candesartan cilexetil,
2-Desethoxy-2-oxo-1H-1-ethyl candesartan cilexetil,
Candesartan Cilexetil Impurity C,
Candesartan Cilexetil Impurity C,
Candesartan Cilexetil EP Impurity C,
(+/-)-1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(N -ethyl-tetrazol-5-yl) biphenyl-4-yl)methyl(benzimidazole-7-carboxylate,
(1RS)-1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 3-((2'-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate,
1H-Benzimidazole-4-carboxylic acid, 3-((2'-(1-ethyl-1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-2,3-dihydro-2-oxo-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester,
FT-0665930,
A1-01749,
(RS)-1-[[Cyclohexyloxy)carbonyl]oxy]ethyl-3-[[2 inverted exclamation mark -(1-ethyl-1H-tetrazol-5-yl)-4-biphenylyl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate,
2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil; Candesartan Cilexetil Impurity C; Candesartan Cilexetil EP Impurity C,
2-Hydroxy-1-[[2'-(1-ethyl-1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl Ester,
UNII-3705I533V3,
DEGBAMTUFHKMQR-UHFFFAOYSA-N,
3705I533V3,